- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
MaxCyte Inc (MXCT)
MaxCyte Inc stock price live, this page displays LON MXCT stock exchange data. View the MXCT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the MaxCyte Inc real time stock price chart below.
What Is the MaxCyte Inc Stock Price Today?
The MaxCyte Inc stock price today is 165.50.
What Is the Stock Symbol for MaxCyte Inc?
The stock symbol for MaxCyte Inc is "MXCT."
What Stock Exchange Does MaxCyte Inc Trade On?
MaxCyte Inc is listed and trades on the London stock exchange.
Is MaxCyte Inc a Good Stock to Buy?
Determining whether MaxCyte Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MXCT quote. (ISIN: US57777K1060)
What Is the MaxCyte Inc Stock Price Today?
The MaxCyte Inc stock price today is 165.50.
What Is the Stock Symbol for MaxCyte Inc?
The stock symbol for MaxCyte Inc is "MXCT."
What Stock Exchange Does MaxCyte Inc Trade On?
MaxCyte Inc is listed and trades on the London stock exchange.
Is MaxCyte Inc a Good Stock to Buy?
Determining whether MaxCyte Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MXCT quote. (ISIN: US57777K1060)
165.50
-2.00(-1.19%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
161.15
172.25
52 wk Range
160.00
407.84
MXCT Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
MXCT is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
161.15172.25
52 wk Range
160.00407.84
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
MXCT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
525.24
Upside
+217.37%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings downwards for the upcoming period
- MaxCyte NAQ receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- MaxCyte NAQ receives Investment Bank Analyst Rating Update
- Investing.com
Pro
MaxCyte Inc Company Profile
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
Compare MXCT to Peers and Sector
Metrics to compare | MXCT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMXCTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.7x | 5.2x | −0.4x | |
PEG Ratio | 0.46 | 0.06 | 0.00 | |
Price/Book | 1.2x | 3.5x | 2.6x | |
Price / LTM Sales | 6.3x | 3.1x | 2.9x | |
Upside (Analyst Target) | 217.4% | 121.0% | 54.4% | |
Fair Value Upside | Unlock | 22.2% | 9.3% | Unlock |
Analyst Ratings
6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 525.24
(+217.37% Upside)
Earnings
Latest Release
Mar 11, 2025
EPS / Forecast
-0.10 / --
Revenue / Forecast
8.69M / --
FAQ
What Is the MaxCyte (MXCT) Stock Price Today?
The MaxCyte stock price today is 165.50
What Stock Exchange Does MaxCyte Trade On?
MaxCyte is listed and trades on the London Stock Exchange stock exchange.
What Is the Stock Symbol for MaxCyte?
The stock symbol for MaxCyte is "MXCT."
What Is the MaxCyte Market Cap?
As of today, MaxCyte market cap is 175.96M.
What Is MaxCyte's Earnings Per Share (TTM)?
The MaxCyte EPS (TTM) is -0.40.
From a Technical Analysis Perspective, Is MXCT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has MaxCyte Stock Split?
MaxCyte has split 0 times.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.